Table 5.
Longitudinal studies focusing on PPI treatment.
| Author | Type | Sample | Selection criteria | Measure | Risk of bias/EBM level | Result |
|---|---|---|---|---|---|---|
| Vaezi et al. (2010)33 | Controlled randomized test | 75 | Postnasal drip with no CRS or allergy | Symptoms evaluation and pH-metry using PPI | High/ | Important improvement of symptoms compared to control group |
| DiBaise et al. (2002)34 | Cohort | 11 | CRS that is refractory to medical and surgical treatment | Symptoms score, pH-metry via dual-channel tube, nasolaryngoscopy after PPI treatment for 3 months | Mod/4 | Mild improvement of symptoms |
| Pincus et al. (2006)35 | Cohort | 30 | CRS that is refractory to medical and surgical treatment | Evaluation of symptoms and pH-metry using PPI | High/4 | 25 of 30 had LPR or nasal reflux events. 14 of 15 improved with PPI |
| Durmus et al. (2010)36 | Case–control | 50 vs. 30 | GERD and LPR vs. absence of GERD | Nasal saccharin test and clinical evaluation before and after treatment with PPI | Mod/2b | No difference on saccharin test. There was significant improvement of symptoms |
CRS, chronic rhinosinusitis; LPR, laryngopharyngeal reflux; PPI, proton pump inhibitor; GERD, gastroesophageal reflux disease.